Robert Rapaport, MD — New York, New York

Robert Rapaport, MD is a clinical research site located in New York, New York, United States.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Robert Rapaport, MD has participated in 1 clinical trials.

Therapeutic areas: Growth Hormone Insensitivity Syndrome (GHIS), Laron Syndrome.

Sponsors: Insmed Incorporated.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Robert Rapaport, MD?

Robert Rapaport, MD has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Robert Rapaport, MD conducted?

Robert Rapaport, MD has 1 clinical trials on record. Their work covers Growth Hormone Insensitivity Syndrome (GHIS), Laron Syndrome.

Is Robert Rapaport, MD accredited by Crixeo Health?

Robert Rapaport, MD has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Robert Rapaport, MD?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.